Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MICHAEL DAVID SHAPIRO

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1215063920
CMS profile
9158
Location
WINSTON-SALEM, NC

General Payments · PY2019–2025

$162,830.94

  • Reported across 144 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$56,754.07

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $24,435.36 2
Esperion Therapeutics, Inc. $8,250.00 4
Merck Sharp & Dohme Corporation $7,745.55 9
Eli Lilly and Company $6,800.00 2
NOVARTIS PHARMACEUTICALS CORPORATION $6,573.83 3
Novo Nordisk AS $2,355.00 1
CHIESI USA, INC. $300.00 1
Regeneron Pharmaceuticals, Inc. $159.33 2
AstraZeneca UK Limited $135.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,686.53 19
PY2020 $19,908.94 27
PY2021 $11,790.13 6
PY2022 $13,349.77 19
PY2023 $13,069.49 16
PY2024 $38,272.01 32
PY2025 $56,754.07 25

Payment records · PY2025 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $44.93 08/04/2025 Food and Beverage Undisputed 06/30/2026 1228513009 CMS
Amgen Inc. $24,390.43 10/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1226908118 CMS
AstraZeneca UK Limited $135.00 11/09/2025 Food and Beverage Undisputed 06/30/2026 1202972038 CMS
Chiesi USA, Inc. $300.00 12/10/2025 Honoraria Undisputed 06/30/2026 1250648422 CMS
Eli Lilly and Company $4,000.00 11/21/2025 Consulting Fee Undisputed 06/30/2026 1186766424 CMS
Eli Lilly and Company $2,800.00 11/21/2025 Consulting Fee Undisputed 06/30/2026 1186792625 CMS
Esperion Therapeutics, Inc. $2,640.00 03/28/2025 Consulting Fee Undisputed 06/30/2026 1250425524 CMS
Esperion Therapeutics, Inc. $2,640.00 06/23/2025 Consulting Fee Undisputed 06/30/2026 1250425526 CMS
Esperion Therapeutics, Inc. $990.00 07/08/2025 Consulting Fee Undisputed 06/30/2026 1250425528 CMS
Esperion Therapeutics, Inc. $1,980.00 10/03/2025 Consulting Fee Undisputed 06/30/2026 1250425530 CMS
Merck Sharp & Dohme LLC $640.00 06/25/2025 Consulting Fee Undisputed 06/30/2026 1238005488 CMS
Merck Sharp & Dohme LLC $640.00 08/06/2025 Consulting Fee Undisputed 06/30/2026 1238031576 CMS
Merck Sharp & Dohme LLC $2,968.75 10/20/2025 Consulting Fee Undisputed 06/30/2026 1238039462 CMS
Merck Sharp & Dohme LLC $199.31 11/10/2025 Travel and Lodging Undisputed 06/30/2026 1238040517 CMS
Merck Sharp & Dohme LLC $35.00 11/11/2025 Food and Beverage Undisputed 06/30/2026 1238009314 CMS
Merck Sharp & Dohme LLC $24.99 11/11/2025 Food and Beverage Undisputed 06/30/2026 1238034376 CMS
Merck Sharp & Dohme LLC $50.00 11/11/2025 Food and Beverage Undisputed 06/30/2026 1238037580 CMS
Merck Sharp & Dohme LLC $3,037.50 11/24/2025 Consulting Fee Undisputed 06/30/2026 1238006112 CMS
Merck Sharp & Dohme LLC $150.00 11/24/2025 Travel and Lodging Undisputed 06/30/2026 1238032906 CMS
Novartis Pharmaceuticals Corporation $3,600.00 01/27/2025 Consulting Fee Undisputed 06/30/2026 1200452133 CMS
Novartis Pharmaceuticals Corporation $48.83 11/09/2025 Food and Beverage Undisputed 06/30/2026 1200452131 CMS
Novartis Pharmaceuticals Corporation $2,925.00 11/21/2025 Consulting Fee Undisputed 06/30/2026 1200452129 CMS
Novo Nordisk Inc $2,355.00 01/01/2025 Consulting Fee Undisputed 06/30/2026 1188393254 CMS
Regeneron Pharmaceuticals, Inc. $15.48 03/14/2025 Food and Beverage Undisputed 06/30/2026 1213243427 CMS
Regeneron Pharmaceuticals, Inc. $143.85 11/25/2025 Food and Beverage Undisputed 06/30/2026 1213243429 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.